Spark Therapeutics to Participate in Multiple Meetings in May
PHILADELPHIA, May 03, 2017 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ:ONCE), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, announced today that members of company management or key investigators …